查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1197282

充气设备市场 - 增长、趋势和预测 (2023-2028)

Inflation Devices Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 112 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

在预测期内，充气设备市场预计将以 4.7% 的复合年增长率增长。

COVID-19 正在以多种方式影响对医疗设备的需求。 重症监护室对用于治疗 COVID-19 患者的设备的需求有所增加，而其他设备则因治疗延误和取消而陷入困境。 但是，很少有感染 COVID-19 的人患心血管疾病的风险增加的例子。 2022 年 2 月发表在《自然医学》上的一项研究发现，急性 COVID-19 的倖存者患心血管疾病的风险更大，一年的负担也更大。 因此，血管成形术必须用于治疗心血管疾病，例如需要充气装置的冠状动脉疾病。 因此，市场有望在后 COVID-19 时期和未来几年产生积极影响。

受老龄化人群泌尿和心血管疾病发病率上升、发达地区微创手术需求增加、微创手术报销等因素影响，充气器械市场正在增长。我来了。

主要亮点

  • 根据世卫组织发布的《2022 年老龄化与健康事实》，全球 60 岁及以上人口将在 2015 年至 2050 年间从 12% 增加到 22%。 到 2050 年，大约 80% 的老年人将生活在低收入和中等收入国家。 衰老是影响心血管和泌尿系统疾病的重要因素。 因此，随着人口老龄化的加剧，对这些疾病的血管成形术等管理设备的需求将增加。 此外，根据欧洲心臟网络2021公布的数据，欧盟有超过6000万人患有心血管疾病。 每年新增确诊病例超过1300万例。 因此，心血管疾病发病率的增加和老年人口的增加将增加疾病管理方法，推动预测期内市场的增长。
  • 但是，与手术相关的高成本和并发症（例如感染和出血风险）预计会阻碍市场增长。

充气设备市场趋势

模拟显示的充气设备领域预计将占据很大的市场份额

模拟显示充气仪用于在血管成形术过程中为球囊充气/放气，并具有精确的模拟式压力控制计。 模拟显示充气设备部分预计将在充气设备市场占有更大的份额。 该细分市场的绝对高收入份额是由于模拟充气设备的低成本和便携性。 由于与数字充气设备相比成本较低，越来越多的患者采用模拟充气设备，也推动了市场的增长。

除了模拟显示器的优势外，心血管疾病患病率上升、老年人口增加以及对微创手术的偏好上升等其他驱动因素正在刺激对该细分市场的需求并推动市场向前发展。预计这将是有用的 根据澳大利亚健康与福利研究所 2022 年澳大利亚统计局 2020-21 NHS 自我报告的数据，估计 18 岁及以上的澳大利亚人（占成年人口的 2.9%）在 2020-2021 年患有慢性心脏病它一直。 此外，该地区冠状动脉疾病的高患病率导致更多的心臟介入手术，预计这将支持本研究的市场增长。

模拟显示充气设备是介入气球充气的黄金标准。 大多数繁忙的介入实验室可以依靠模拟显示充气设备来执行他们的程序。 因此，在预测期内，慢性心脏病的益处和患病率上升预计将在研究市场中占有重要的市场份额。

预计在预测期内北美将占据很大的市场份额

预计北美将在充气设备市场中占据很大份额。 这是由于需要介入手术的疾病高发、微创技术知识的增加以及该地区微创设备的使用越来越多。 例如，根据 CDC 2022，美国四分之一的死亡是由于心脏病，每年影响约 659,000 人，导致对血管成形术的需求增加。 这推动了该地区的充气设备市场。

同样，根据加拿大心臟和中风基金会发布的数据，到 2022 年 2 月，加拿大将有 75 万名心力衰竭患者，每年将报告 10 万例这种致命疾病的新病例。我在这里。 因此，血管成形术等最小限度的手术干预有助于排除心血管风险。 因此，心脏病的显着流行可以推动该地区的市场。

此外，市场上的主要参与者正在共同开发支持市场增长的血管通路产品。 例如，2022 年 8 月，Teleflex, Inc. 赢得了美国最大的会员制医疗绩效改善公司 Vizient, Inc. 的中央静脉通路产品供应合同。 这些合同帮助公司通过血管成形术等外科手术进入血管，并使市场在预测期内增长。

因此，由于上述因素，预计北美将占据很大的市场份额。

充气设备市场竞争对手分析

充气设备市场竞争激烈，由多家大型企业组成。 从市场份额的角度来看，一些主要参与者目前主导着市场。 一些主要参与者正在积极收购其他公司以巩固其在全球的市场地位，而另一些则正在分销其产品。 主要参与者包括 Johnson & Johnson Service Inc.、Merit Medical Systems、Argon Medical、B.Brown SE、Teleflex、Terumo Medical、ConMed、Medtronic、BD、Boston Scientific Corporation 等。

其他福利。

  • Excel 格式的市场预测 (ME) 表
  • 3 个月的分析师支持

内容

第一章介绍

  • 研究假设和市场定义
  • 调查范围

第二章研究方法论

第 3 章执行摘要

第四章市场动态

  • 市场概览
  • 市场驱动因素
    • 老年人泌尿系统和心血管疾病的发病率增加
    • 发达国家对微创手术的需求增加，医疗报销增加
  • 市场製约因素
    • 手术费用高
    • 手术相关并发症，例如感染和出血风险
  • 波特的五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分（基于价值的市场规模：100 万美元）

  • 按显示类型
    • 模拟显示
    • 数字显示
  • 通过申请
    • 介入心脏病学
    • 介入放射学
    • 外周血管治疗
    • 消化外科
    • 泌尿外科领域
    • 其他应用
  • 最终用户
    • 医院和诊所
    • 门诊手术中心
    • 其他最终用户
  • 区域信息
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东
      • 海湾合作委员会
      • 南非
      • 其他中东地区
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章竞争格局

  • 公司简介
    • Johnson & Johnson Services Inc.
    • Merit Medical Systems
    • ARGON MEDICAL
    • B. Braun SE
    • Teleflex Incorporated
    • Terumo Medical Corporation
    • CONMED Corporation
    • Medtronic
    • BD（Becton, Dickinson and Company）
    • Boston Scientific Corporation

第7章 市场机会今后动向

简介目录
Product Code: 67476

The inflation devices market is expected to register a CAGR of 4.7% over the forecast period.

In many ways, COVID-19 has influenced the demand for medical equipment. While there was an increase in demand for the devices used to treat COVID-19 patients in intensive care, other devices suffered due to postponed or canceled treatments. However, there are few instances of individuals infected with COVID-19 being at increased risk of cardiovascular disease. According to the study report published by Nature Medicine in February 2022, in survivors with acute COVID-19, there is a significant risk of cardiovascular disease and a one-year burden. Hence to manage cardiovascular diseases like coronary artery disease, angioplasty should be used, which needs inflation devices. Thus the market is expected to have a positive impact during the post-COVID-19 period and in the coming years.

The inflation devices market is growing due to certain factors, such as the increased incidences of urological diseases and cardiovascular diseases in the geriatric population and a rise in the demand for minimally invasive procedures and medical reimbursement for minimally invasive procedures in developed regions.

Key Highlights

  • According to the WHO facts of aging and health 2022, people over 60 years in the world will increase from 12% to 22% between 2015 and 2050. About 80% of senior citizens will reside in low- and middle-income nations by 2050. Aging is a critical factor that influences cardiovascular and urological diseases. Hence, the demand for management devices like angioplasty for those diseases increases with the growing aging population. Furthermore, according to the data published by the European Heart network 2021, more than 60 million people in the European Union have cardiovascular illnesses. Every year, over 13 million new cases are identified. Thus, the increased incidences of cardiovascular diseases and the senior population increase the disease management methods and drive the market's growth over the forecast period.
  • However, the high cost and complications associated with procedures, such as the risk of infection and bleeding, are expected to hamper the market growth.

Inflation Devices Market Trends

Analog Display Inflation Devices Segment is Expected to Hold a Significant Share in the Market

An analog display inflation device is used to inflate/ deflate a balloon during the angioplasty procedure and has a precise analog-type pressure control gauge. The analog display inflation devices segment is expected to account for a more significant share of the inflation devices market. This segment's dominance in this segment's revenue share is due to the low cost and portability of analog inflation devices. Also, an increase in the adoption of analog inflation devices by patients compared to that of digital inflation devices due to less cost fuel the market's growth.

Along with the advantages of the analog display, the other driving factors, like the growing prevalence of cardiovascular diseases, the rising geriatric population, and the rising preference for minimally invasive surgeries, are expected to fuel the demand for the segment and help propel the market. According to the Australian Institute of Health and Welfare 2022, based on self-reported data from the Australian Bureau of Statistics 2020-21 NHS, an estimated 571,000 Australians aged 18 and over (2.9% of the adult population) had chronic cardiac illnesses in 2020-2021. Additionally, more cardiology intervention operations are being performed due to the high prevalence of coronary artery disease in the area, which is anticipated to support market growth in the study.

An analog display inflation device is a gold standard for interventional balloon inflation. Most busy interventional labs can rely on the analog display inflation device for their procedures. Hence the advantages and rising prevalence of chronic heart diseases are expected to occupy a significant market share in the studied market over the forecast period.

North America is Expected to have a Significant Share in the Market over the Forecast Period

North America is anticipated to account for a significant share of the inflation devices market. The high prevalence of disorders needing interventional procedures, increased knowledge of minimally invasive techniques, and expanding use of minimally invasive devices in the area are all contributing factors. For instance, according to CDC 2022, one in every four deaths in the United States is caused by heart disease, which affects roughly 659,000 people annually, resulting in higher demand for angioplasty procedures. This drives the inflation devices market in the region.

Similarly, per the data published by the Heart and Stroke Foundation of Canada, in February 2022, 750,000 heart failure sufferers in Canada and 100,000 new cases of this fatal disease are reported each year. Hence minimal surgical interventions like angioplasty can help rule out a cardiovascular risk. Thus the significant prevalence of heart diseases can drive the market in the region.

Furthermore, the major players in the market are collaborating to develop vascular access products that help the market grow. For instance, in August 2022, Teleflex Incorporated was awarded a contract to supply Central Venous Access products from Vizient, Inc., the nation's largest member-driven healthcare performance improvement company. These contracts can help the companies to access the blood vessels through surgical interventions like angioplasty and allow the market to grow over the forecast period.

Therefore, owing to the abovementioned factors, North America is expected to hold a significant market share.

Inflation Devices Market Competitor Analysis

The inflation devices market is moderately competitive and consists of several major players. In terms of market share, a few of the major players are currently dominating the market. Some prominent players are vigorously acquiring other companies to consolidate their market positions across the globe and while others are distributing products. Some of the major players in the market are Johnson & Johnson Services Inc., Merit Medical Systems, ARGON MEDICAL, B. Braun SE, Teleflex Incorporated, Terumo Medical Corporation, CONMED Corporation, Medtronic, BD, and Boston Scientific Corporation.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increased Incidences of Urological Diseases and Cardiovascular Diseases in Geriatric Population
    • 4.2.2 Rise in the Demand for Minimal Invasive Procedures and Medical Reimbursements in Developed Regions
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Procedures
    • 4.3.2 Complications Associated in Procedures such as Risk of Infection and Bleeding
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Display Type
    • 5.1.1 Analog Display
    • 5.1.2 Digital Display
  • 5.2 By Application
    • 5.2.1 Interventional Cardiology
    • 5.2.2 Interventional Radiology
    • 5.2.3 Peripheral Vascular Procedures
    • 5.2.4 Gastroenterology Procedures
    • 5.2.5 Urology Procedures
    • 5.2.6 Other Applications
  • 5.3 By End User
    • 5.3.1 Hospitals and Clinics
    • 5.3.2 Ambulatory Surgical Center
    • 5.3.3 Other End Users
  • 5.4 By Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Johnson & Johnson Services Inc.
    • 6.1.2 Merit Medical Systems
    • 6.1.3 ARGON MEDICAL
    • 6.1.4 B. Braun SE
    • 6.1.5 Teleflex Incorporated
    • 6.1.6 Terumo Medical Corporation
    • 6.1.7 CONMED Corporation
    • 6.1.8 Medtronic
    • 6.1.9 BD (Becton, Dickinson and Company)
    • 6.1.10 Boston Scientific Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS